Leading Medical Cannabis Research Company Alternate Health Corp. to Present at Planet MicroCap Showcase 2017

PLANO, Texas--()--Alternate Health Corp (CSE:AHG) (OTC:AHGIF), a diverse healthcare company that uses its expertise in technology and data analytics to revolutionize patient care and research in the emerging medical cannabis industry, will present a business update at the Planet MicroCap Showcase conference in Las Vegas at 9 a.m. PT on Thursday, April 27, 2017.

Dr. Jamison Feramisco, CEO of Alternate Health, will lead the presentation and also be meeting with investors one-on-one at the conference. Alternate Health is among the top performing medical cannabis companies in the world today. With American Medical Association-approved educational programs, software and patented delivery medical systems, Alternate Health Corp is positioned for rapid growth. To schedule an in-person meeting, contact Robert Kraft, editor-in-chief of StockNewsNow.com, the conference organizer, at 424-227-9018 or rkraft@snnwire.com. Visit www.PlanetMicroCapShowcase.com for more information.

The Planet MicroCap Showcase is a conference that brings together promising companies and the top dealmakers in microcap finance for three days of company presentations, one-on-one meetings, and networking.

About Alternate Health Corp.

Alternate Health Corp is a diversified healthcare company that uses its expertise in technology to revolutionize patient care and service delivery in both traditional and complementary medical fields. With investments in research, education and cutting edge technology, Alternate Health is a leader in software applications and processing systems for the medical industry using proprietary technology platforms. Through its subsidiaries, Alternate Health offers services ranging from medical practice and controlled substance management software to blood analysis and toxicology labs, to clinical research and continuing education programs. Alternate Health’s goal is to continue to lead the medical industry with data-driven results in patient care and product development.

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. Statements included in this announcement, including statements concerning our plans, intentions and expectations, which are not historical in nature are intended to be, and are hereby identified as “forward-looking statements”. Forward-looking statements may be identified by words including “anticipates”, “believes”, “intends”, “estimates”, “expects” and similar expressions. The Company cautions readers that forward-looking statements, including without limitation those relating to the Company’s future operations, business prospects and financing plans, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward looking statements.

Contacts

For Alternate Health Corp:
Graham Buck
Graham.Buck@finsbury.com

Contacts

For Alternate Health Corp:
Graham Buck
Graham.Buck@finsbury.com